Boston Scientific Corporation
BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardiovā¦ read more
Healthcare
Medical Devices
34 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$42.98
Price-0.28%
-$0.12
1Y
Price
Market Cap
$63.884b
Large
Price/Earnings 3y Avg5y Avg
13.9x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+25.5%
EBITDA Margin+16.7%
Net Profit Margin+23.5%
Free Cash Flow Margin+25.5%
EBITDA Margin+16.7%
Net Profit Margin+23.5%
Free Cash Flow MarginRevenue
$20.996b
+4.6%
1y CAGR+14.0%
3y CAGR+13.6%
5y CAGREarnings
$3.667b
+27.1%
1y CAGR+33.0%
3y CAGR+56.8%
5y CAGREPS
$2.46
+26.8%
1y CAGR+32.9%
3y CAGR+59.2%
5y CAGRBook Value
$25.172b
$45.216b
Assets$20.044b
Liabilities$12.624b
DebtDebt to Assets
27.9%
2.2x
Debt to EBITDAFree Cash Flow
$3.625b
-0.9%
1y CAGR+30.9%
3y CAGR+44.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company